Molecular mimicry: Its evolution from concept to mechanism as a cause of autoimmune diseases

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 33, Issue 3, 2014, Pages 158-165

  Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CYTOTOXIC T LYMPHOCYTE; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; MEASLES VIRUS; MOLECULAR MIMICRY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REITER SYNDROME; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; HUMAN; IMMUNOLOGY; INFECTION; METABOLISM; MICROBIOLOGY; VIROLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS; AUTOIMMUNE DISEASES; HUMANS; INFECTION; MOLECULAR MIMICRY; T-LYMPHOCYTES;

EID: 84901632137     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2013.0090     Document Type: Article

References (46)

1. Kolmer G: The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1984. Derivation and diversification of monoclonal antibodies. Scand J Immunol 1993;37:117-129.
2. Fujinami RS, Oldstone M.B.A., Wroblewska Z, Frankel ME, and Koprowski H: Molecular mimicry in virus infection: Cross-reaction of measles phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983;80:2346-2350. (Pubitemid 13097186)
3. Lane DP, and Hoeffler WK: SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature 1980;288:167-170.
4. Oldstone M.B.A.: Molecular mimicry, microbial infection, and autoimmune disease: Evolution of the concept. Curr Topics Microbiol Immunol 2005;296:1-17, 65-88.
5. Oldstone M.B.A.: Molecular mimicry and immune-mediated diseases. FASEB J 1998;12:1255-1265.
6. Dales S, Fujinami RS, and Oldstone M.B.A.: Infection with vaccinia favors the selection of hybridomas synthesizing auto-Antibodies against intermediate filaments, among them one cross-reacting with the virus hemagglutinin. J Immunol 1983;131:1546-1553. (Pubitemid 13048921)
7. Shrinivasappa J, Saegusa J, Prabhakar B, Gentry M, Buchmeier M, Wiktor T, Koprowski H, Oldstone M, and Notkins A: Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397-401. (Pubitemid 16147963)
8. Fujinami RS, and Oldstone M.B.A.: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985;230: 1043-1045. (Pubitemid 16192692)
9. Wucherpfennig KW, and Strominger JL: Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelin basic protein. Cell 1995;80:695-705.
10. Hudrisier D, Riond J, Burlet-Schiltz O, von Herrath MB, Lewicki H, Monsarrat B, Oldstone M.B.A., and Gairin JE: Structural and functional identification of major histocompatibility complex class-I-restricted self-peptides as naturally occurring molecular mimics of viral antigens. J Biol Chem 2001;276:19396-19403.
11. Dyrberg T, and Oldstone M.B.A.: Peptides as probes to study molecular mimicry and virus-induced autoimmunity. Curr Topics Microbiol Immunol 1986;130:25-37.
12. Dyrberg T, Petersen JS, and Oldstone M.B.A.: Immunological cross-reactivity between mimicking epitopes on a virus protein and a human autoantigen depends on a single amino acid residue. Clin Immunol Immunopathol 1990;54:290-297. (Pubitemid 20042229)
13. Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, Strominger JL, and Hafler DA: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-290. (Pubitemid 24012993)
14. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, and Wucherpfennig KW: Crystal structure of HLA-DR2 (DRA 0101, DRB1 1501) complexed with a peptide from human myelin basic protein. J Exp Med 1998;188:1511-1520.
15. Mason D: A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19:395-404.
16. Yin Y, and Mariuzza RA: The multiple mechanisms of T cell receptor cross-reactivity. Immunity 2009;31:849-851.
17. Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, Bharadwaj M, Kjer-Nielsen L, Saunders PM, Wilce MCJ, Crawford F, Stadinsky B, Jackson D, Brooks AG, Purcell AW, Kappler JW, Burrows SR, Rossjohn J, and McCluskey J: T cell allorecognition via molecular mimicry. Immunity 2009;31:897-908.
18. Oldstone M.B.A.: Molecular mimicry and autoimmune disease. Cell 1987;50:819-820.
19. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, and Griffin JW: Acute motor axonal neuropathy: An antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644. (Pubitemid 26357889)
20. van der Meche FG, and van Doorn PA: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies. Ann Neurol 1995;37:S14-S31.
21. Yuki N, Tagawa Y, and Handa S: Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1996;70: 1-6. (Pubitemid 26323561)
22. Zhao Z-S, Granucci F, Yeh L, Schaffer P, and Cantor H: Molecular mimicry by herpes simplex virus type 1: Autoimmune disease after viral infection. Science 1997;79: 1344-1347.
23. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, and MacLaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-2129. (Pubitemid 24348254)
24. MacLaren NK, and Alkinson MA: Insulin-dependent diabetes mellitus: The hypothesis of molecular mimicry between islet cell antigens and microorganisms. Mol Med Today 1997;3:76-83.
25. Karges WJ, Ilonen J, Robinson BH, and Dosch HM: Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms. Mol Aspects Med 1995;16:79-213.
26. Solimena S, and DeCamilli P: Coxsackieviruses and diabetes. Nat Med 1995;I:25-26.
27. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, and Lew AM: Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1995;1:625-633.
28. Honeyman MC, Stone NL, and Harrison LC: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: Potential for mimicry with rotavirus and other environmental agents. Mol Med 1998;4:231-239. (Pubitemid 28331640)
29. Schwimmbeck PL, Yu TDY, and Oldstone M.B.A.: Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome: Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-181. (Pubitemid 17101898)
30. Schwimmbeck P, and Oldstone M.B.A.: Klebsiella pneumoniae and HLA B27 associated diseases of Reiter's syndrome and ankylosing spondylitis. Curr Topics Microbiol Immunol 1989;145:45-67.
31. von Herrath MG, Evans CF, Horwitz MS, and Oldstone M.B.A.: Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev 1996;152:111-143. (Pubitemid 26362755)
32. Oldstone M.B.A., Nerenberg M, Southern P, Price J, and Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 1991;65:319-331. (Pubitemid 121006061)
33. von Herrath M, Dockter J, and Oldstone M.B.A.: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994;1: 231-242.
34. Evans CF, Horwitz MS, Hobbs MV, and Oldstone M.B.A.: Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996;184:2371-2384. (Pubitemid 27023736)
35. Brewerton D, Caffrey M, Hart F, James D, Nichols A, and Sturrock R: Ankylosing spondylitis and HLA B27. Lancet 1973;i:904-907.
36. Gilliland B, and Mannik M: Ankylosing spondylitis and Reiter's syndrome. In: Principles of Internal Medicine, 10th ed. Harrison TR (Ed). McGraw Hill, New York, 1986, pp. 1986-1988.
37. Gilliland B, and Mannik M: Rheumatoid arthritis. In: Principles of Internal Medicine, 10th ed. Harrison TR (Ed). McGraw Hill, New York, 1986, pp. 1977-1986.
38. Khare SD, Luthra HS, and David CS: Role of HLA-B27 in spondyloarthropathies. Curr Topics Microbiol Immunol 1996;206:85-97.
39. Eastmond CJ, and Woodrow JC: Discordance for ankylosing spondylitis in monozygotic twins. Ann Rheum Dis 1977;36:360.
40. LaFace DM, Vestberg M, Yang Y, Srivastava R, DiSanto J, Flomenberg N, Brown S, Sherman LA, and Peterson PA: Human CD8 transgene regulation of HLA recognition by murine T cells. J Exp Med 1995;182:1315-1325.
41. Tishon A, LaFace DM, Lewicki H, van Binnendijk RS, Osterhaus A, and Oldstone M.B.A.: Transgenic mice expressing human HLA and CD8 molecules generate HLArestricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection. Virology 2000;275:286-293.
42. Hammer RE, Maika SD, Richardson JA, Tang J-P, and Taurog JD: Spontaneous inflammatory disease in transgenic mice expressing HLA-B27 and human b2m: An animal model of HLA-B27-Associated human disorders. Cell 1990;63:1099-1112. (Pubitemid 120034950)
43. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, and Sartor RB: Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996;98:945-953. (Pubitemid 26293312)
44. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, and Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic mice. J Exp Med 1994;180:2359-2364. (Pubitemid 24351619)
45. Schwimmbeck PL, Dyrberg T, Drachman DB, and Oldstone M.B.A.: Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest 1989;84:1174-1180. (Pubitemid 19247588)
46. Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, and Oldstone M.B.A.: CTL escape viral variants. I. Generation and molecular characterization. Virology 1995;210:29-40.